sialagoga composition based on a muscarinic agonist and M3 antagonist alpha-2 adrenergic

摘要

sialagoga composition it comprising, in a suitable pharmaceutically acceptable carrier for peripheral administration, a muscarinic agonist pilocarpine M3 or selected from pilocarpine hydrochloride, characterized by further include an α2 adrenergic antagonist selected from yohimbine or yohimbine hydrochloride.